Company news
Softox Solutions As (OSL:SOFTX) news
Softox Solutions As news releases on 6ix. Latest, Sep 29, 2026: SoftOx Solutions AS: SoftOx attracts renowned inhaled antimicrobial expert Dr. Bruce…
Press releases & updates
SoftOx Solutions AS: SoftOx attracts renowned inhaled antimicrobial expert Dr. Bruce Montgomery to lead Clinical Advisory Board ahead of Phase 2b
September 29, 2026
SoftOx Solutions AS: Half Year Report 2026
September 23, 2026
SoftOx Solutions AS: FIRST PATIENT DOSED IN SIS-03 PROOF-OF-CONCEPT PATIENT TRIAL
August 11, 2026
SoftOx Solutions AS: POSITIVE TOPLINE SAFETY DATA FROM SIS-03 DOSE-ESCALATION PHASE
June 26, 2026
SoftOx Solutions AS: First Quarter Report 2026
June 24, 2026
SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited
June 9, 2026
SoftOx Solutions AS: SIS-03 DOSE-ESCALATION PHASE COMPLETED AND INITIATION OF PROOF-OF-CONCEPT PHASE
June 8, 2026
SoftOx Solutions AS: FIRST PARTICIPANT ENROLLED IN BIODEFENCE-FOCUSED SIS-02 PHASE 1 CLINICAL STUDY
June 5, 2026
SoftOx Solutions AS: Annual Report 2025
May 27, 2026
SoftOx Solutions AS: New Share Capital
April 21, 2026
SoftOx Solutions AS: Fourth Quarter Report 2025
March 25, 2026
SoftOx Solutions AS: First Subject Dosed in Combined Phase 2a Dose-Escalation and Proof-of-Concept Trial (SIS-03)
March 3, 2026
SoftOx Solutions AS: Danish Medicines Agency Approves Phase 2a Trial for SoftOx Inhalation Solution
December 29, 2025
SoftOx Solutions AS: Third Quarter Report 2025
November 26, 2025
SoftOx Solutions AS: GMP Drug Substance Successfully Manufactured - Key Milestone for CF and EDF Clinical Programs
November 14, 2025
SoftOx Solutions AS: SoftOx submits Phase 1 Clinical Trial Application under the European Defence Fund (EDF) Program
October 16, 2025
SoftOx Solutions AS: Private Placement resolved
October 7, 2025